Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-03

Clinical Trial Update: Evaluation of the Safety and Efficacy of Infantile-onset Pompe Disease Gene Therapy Drug [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 1/2 evaluation of a gene therapy for infantile-onset Pompe disease, with the study currently active but not recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Infantile-onset Pompe disease gene therapy

Snippet

Sponsor: GeneCradle Inc | Conditions: Pompe Disease Infantile-Onset | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING